Brought to you by Nuclear Education Online (NEO)                    Volume 3, No. 11         January 2006

Make Plans to Attend APhA Meeting
The deadline for early registration for the 2006 Annual Meeting of the American Pharmacist Association is Feb. 15th.  Go online to register at www.aphameeting.org.  It is a great meeting for nuclear pharmacists with 15 hours of nuclear CE and great fellowship and networking activities.
 
Depreotide Imaging Predicts Breast CA Response to Hormonal Therapy
Researchers reported in the January Journal of Nuclear Medicine an innovative use of somatostatin receptor scintigraphy (SRS).  Tc-99m Depreotide (NeoTect) imaging accurately predicted which women would respond to hormonal therapy.  The current method that examines a sample of breast tissue for estrogen receptors has a low accuracy rate as opposed to the 100% accuracy of SRS imaging found in this study.  For more information or full text article.
 
 
U.S. Market for Diagnostic Radiopharmaceuticals
Bio-Tech Systems has published a comprehensive report of diagnostic radiopharmaceutical markets. U.S. sales of diagnostic radiopharmaceuticals reached $1.53 billion in 2004 and are expected to rise to $3.20 billion by 2010. Radiopharmaceutical sales grew 14.3% in 2004 and should continue growth in the range of 13%-16% through 2008. This growth will be based on introduction of new products, strong demand for cardiology procedures and increased sales of oncology products, particularly FDG for PET imaging.  Nuclear cardiology sales of $1.06 billion in 2004 will increase to $1.89 billion by 2010. For more information..
 
DRAXIS Receives FDA Approval of I-131 Dx Capsules
DRAXIMAGE plans to introduce the new I-131 diagnostic capsules into the U.S. market during the first half of 2006. The I-131 diagnostic capsules will be supplied in several different strengths of radioactivity and  will employ a system of color-coding to allow each patient to be administered the precise dose of radioactive iodine prescribed by their physician.
 
Mallinckrodt Generator Update
Mallinckrodt has announced significant capital investments to improve quality and production capacity.   They expect to return to generator production around March 31, 2006.  View the latest customer letter update...

Feb. 11-12 SNM Mid-Winter Educational Symposium, Tempe, AZ
Feb. 15 Early Registration Deadline for the APhA Annual Meeting
Feb. 18-19 American College of Nuclear Physicians Annual Meeting, Fort Lauderdale, FL
Feb. 28 Deadline to register for tours at the APhA Meeting in San Francisco
Mar 17-21 APhA Annual Meeting, San Francisco
Mar 30-Apr 2 European Symposium on Radiopharmacy, Lucca, Italy
June 3-7 SNM Annual Meeting, San Diego
 

Send your message to a targeted audience of over 1,000 nuclear pharmacists and nuclear professionals.  Advertise in the Nuclear Pharmacy eNewsletter.  

 
2006 Nuclear Education Online
4301 W. Markham #522
Little Rock, AR  72205
501-686-6398
For more information, contact Nicki Hilliard
To subscribe to this mailing list click here.
To view previous issues

Uranium Quick Facts:

Uranium was first discovered in 1798 by analyzing pitchblende samples of silver mines and named after the planet Uranus. Becquerel discovered its radioactive property in 1896 and it wasn't until 1938 that it was discovered that U could be split to release energy.  One ton of natural uranium can produce 40 million hours of electricity, equivalent to burning 16,000 tons of coal or 80,000 barrels of oil.  U is about 1.6 times more dense than lead.  Depleted uranium is used for radiation shielding material.  A gallon of milk weighs about 8 lbs, while a gallon container of U would weigh 150 lbs!

 

Have your nuclear pharmacy technicians been trained in aseptic technique?  NEO has a training program specific to nuclear pharmacy technicians.  Learn more

Which one of the following areas of regulatory control presents the greatest challenge in your practice setting?

  • Joint Commission on Accreditation of Healthcare Organizations (JCAHO)
  •  USP <797> Pharmaceutical Compounding - Sterile Preparations
  • USP <823> Radiopharmaceuticals for Positron Emission Tomography:
    Compounding
  • State Board of Pharmacy

Click here to view the online poll

Response to the previous poll: 

How do you rate the response by the manufacturers to the generator shortage situation? (38 total votes)

A.  Excellent    50.0%
B.  Good  28.9%
C.  Fair  7.9%
D.  Poor  13.2%

50 year old woman diagnosed with Hodgkin's lymphoma.  PET scan revealed tumor involvement and multiple cavitary lung nodules.  Continued...

If this email does not view graphics properly go to http://www.nuclearonline.org/newsletter/Jan06.htm